We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

No golden age

11 January 2017 By Robert Cyran

The president-elect accused the industry of “getting away with murder” on drug prices. Investors had dismissed his earlier pledge to renegotiate costs as campaign rhetoric easily outweighed by tax cuts. The stock drops caused by his latest stance should force a broader rethink.

This content is for Subscribers only

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)